Kim Huynh-Ba

Kim Huynh-Ba serves as an Adjunct Professor of Chemistry at the Lewis College of Science and Letters, Illinois Institute of Technology. Currently, she is the Executive Director of Pharmalytik, a role she combines with her academic affiliation. With 25 years of industry experience, her expertise spans analytical development, strategic drug development, and stability sciences.

• Professional Affiliations: Member of the Executive Committee of the Governing Board of Eastern Analytical Symposium (EAS), former EAS President (2013), and Chair of USP Good Documentation Practices Expert Panel
• Prior Roles: Director of Pharmacopeial Education Department at U.S. Pharmacopeia (USP), and technical leadership positions at AstraZeneca, DuPont, Bristol Myers Squibb, and Wyeth Vaccines

Her research focuses on pharmaceutical stability testing methodologies, regulatory compliance frameworks, and translational drug development strategies. She has authored definitive works on stability testing practices for global markets and pharmacopeial standards.

Kim’s professional contributions include editorial leadership in Springer-published pharmaceutical handbooks and active participation in expert panels shaping industry standards.